Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Kilpatrick

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|November 1, 1990
The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissuesA Butler, C J Elswood, J Burridge, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivoF M Dautzenberg, J Wichmann, J Higelin, et al.
Oncology|June 1, 1996
Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugsC Bountra, J D Gale, C J Gardner, et al.
European Journal of Pharmacology|September 12, 1996
Characterisation of the specific binding of the histamine H3 receptor antagonist radioligand [3H]GR168320J D Brown, C T O'Shaughnessy, G J Kilpatrick, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1987
The influence of aromatic substituents on the binding of substituted benzamides to dopamine D-2 receptors: congruent QSAR and MEP analysesB Testa, N el Tayar, P A Carrupt, et al.
European Journal of Pharmacology|April 29, 1992
The distribution of 5-HT3 recognition sites in the marmoset brainD N Jones, N M Barnes, B Costall, et al.
British Journal of Pharmacology|December 1, 1995
The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040C J Gardner, D J Twissell, T J Dale, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stressF Jenck, J L Moreau, J R Martin, et al.
Neuropharmacology|January 10, 1998
Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortinJ Gottowik, V Goetschy, S Henriot, et al.
Regulatory Peptides|August 27, 1996
GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activityC J Gardner, D R Armour, D T Beattie, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|November 1, 1990
The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissuesA Butler, C J Elswood, J Burridge, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivoF M Dautzenberg, J Wichmann, J Higelin, et al.
Oncology|June 1, 1996
Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugsC Bountra, J D Gale, C J Gardner, et al.
European Journal of Pharmacology|September 12, 1996
Characterisation of the specific binding of the histamine H3 receptor antagonist radioligand [3H]GR168320J D Brown, C T O'Shaughnessy, G J Kilpatrick, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1987
The influence of aromatic substituents on the binding of substituted benzamides to dopamine D-2 receptors: congruent QSAR and MEP analysesB Testa, N el Tayar, P A Carrupt, et al.
European Journal of Pharmacology|April 29, 1992
The distribution of 5-HT3 recognition sites in the marmoset brainD N Jones, N M Barnes, B Costall, et al.
British Journal of Pharmacology|December 1, 1995
The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040C J Gardner, D J Twissell, T J Dale, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stressF Jenck, J L Moreau, J R Martin, et al.
Neuropharmacology|January 10, 1998
Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortinJ Gottowik, V Goetschy, S Henriot, et al.
Regulatory Peptides|August 27, 1996
GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activityC J Gardner, D R Armour, D T Beattie, et al.
Pageof 6